Literature DB >> 16917918

Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue.

George J Brewer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 16917918     DOI： 10.1002/ajh.20704

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report.

Authors:  JoAn R Laes; David M Williams; Jon B Cole
Journal:  J Med Toxicol       Date:  2015-12

2.  Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy.

Authors:  Marie-Hélène Odièvre; Névéna Danékova; Bettina Mesples; Myriam Chemouny; Nathalie Couque; Nathalie Parez; Rolande Ducrocq; Jacques Elion
Journal:  Int J Hematol       Date:  2011-04-12       Impact factor: 2.490

3.  Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency.

Authors:  Wing Y Au; Chun-Wai Ngai; Wai-Ming Chan; Rock Y Y Leung; See-Ching Chan
Journal:  Ann Hematol       Date:  2011-02-08       Impact factor: 3.673

Review 4.  G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.

Authors:  Lucio Luzzatto; Elisa Seneca
Journal:  Br J Haematol       Date:  2013-12-28       Impact factor: 6.998
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.